Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

MRNS Marinus Pharmaceuticals

Watchlist
6.530
-0.125-1.88%
Close  02/03 16:00 ET
6.600
+0.070+1.07%
Post Mkt Price 02/03 17:09 ET
High
6.750
Open
6.600
Turnover
3.12M
Low
6.480
Pre Close
6.655
Volume
470.41K
Market Cap
324.00M
P/E(TTM)
Loss
52wk High
12.370
Shares
49.62M
P/E(Static)
Loss
52wk Low
3.465
Float Cap
213.15M
Bid/Ask %
0.00%
Historical High
82.880
Shs Float
32.64M
Volume Ratio
1.39
Historical Low
3.080
Dividend TTM
--
Div Yield TTM
--
P/B
4.16
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.44%
Amplitude
4.06%
Avg Price
6.628
Lot Size
1
Float Cap
213.15M
Bid/Ask %
0.00%
Historical High
82.880
Shs Float
32.64M
Volume Ratio
1.39
Historical Low
3.080
Dividend TTM
--
P/B
4.16
Dividend LFY
--
Turnover Ratio
1.44%
Amplitude
4.06%
Avg Price
6.628
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded by Geoffrey E. Chaiken, Harry H. Penner Jr., Vincent A. Pieribone and Kenneth R. Shaw on August 14, 2003 and is headquartered in Radnor, PA.
CEO: Dr. Scott Braunstein, M.D.
Market: NASDAQ
Listing Date: 07/31/2014
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist